New glaucoma treatment eyed by UTHSC faculty member's startup OculoTherapy
November 30, 2021 at 15:12 PM EST
OculoTherapy is developing a new therapeutic for glaucoma — the most common cause of irreversible blindness worldwide — with an eye drop that could target both factors of the disease that lead to vision loss.
